Skip to content

Stockholders to Vote on Transactions with Misys

CHICAGO, Aug. 22 /PRNewswire-FirstCall/ — Allscripts Healthcare
Solutions, Inc. (“Allscripts”), the leading provider of clinical software,
connectivity and information solutions that physicians use to improve
healthcare, announced today that it filed a definitive proxy statement with
the U.S. Securities and Exchange Commission on Thursday, August 21, 2008 in
respect of the proposed transactions involving Allscripts, Misys plc (“Misys”)
and Misys Healthcare Systems LLC (“MHS”), a wholly owned subsidiary of Misys,
as announced on March 18, 2008. Allscripts further announced that it will
hold its annual meeting of stockholders on Monday, September 22, 2008, at
10:00 a.m. Central Time, to approve certain actions required to be taken by
Allscripts in connection with the proposed transactions, among other matters.
The meeting will be held at One South Dearborn Street, Chicago, Ill. For more
information, please see the definitive proxy statement.


The Allscripts board of directors has approved the merger agreement with
Misys and recommends approval of the share issuance and related transactions
contemplated by the merger agreement by Allscripts stockholders. Completion
of the transaction is subject to certain conditions, including approvals by
the stockholders of Allscripts and the shareholders of Misys and other
customary closing conditions. Subject to the satisfaction of these closing
conditions, the transactions are expected to be completed on or about
September 26, 2008.

About Allscripts

Allscripts (Nasdaq: MDRX) is the leading provider of clinical software,
connectivity and information solutions that physicians use to improve
healthcare. The company’s unique solutions inform, connect and transform
healthcare, delivering improved care at lower cost. More than 40,000
physicians and thousands of other healthcare professionals in clinics,
hospitals and extended care facilities nationwide utilize Allscripts to
automate everyday tasks such as writing prescriptions, documenting patient
care, managing billing and scheduling, and safely discharging patients, as
well as to connect with key information and stakeholders in the healthcare
system. To learn more, visit

Additional Information and Where to Find It

This communication is being made in respect of the proposed business
combination involving a subsidiary of Allscripts and MHS, a wholly owned
subsidiary of Misys. In connection with this proposed transaction, Allscripts
has filed with the Securities and Exchange Commission (the “SEC”) a definitive
proxy statement. On August 22, 2008, Allscripts is mailing the definitive
proxy statement and proxy card to its stockholders of record as of August 15,
Investors and security holders can obtain copies of Allscripts’ materials (and
all other offer documents filed with the SEC) when available, at no charge on
the SEC’s website: Copies can also be obtained at no
charge by directing a request for such materials to Allscripts at 222
Merchandise Mart Plaza, Suite 2024, Chicago, Illinois 60654, Attention: Lee
Shapiro, Secretary. Investors and security holders may also read and copy any
reports, statements and other information filed by Allscripts with the SEC, at
the SEC public reference room at 100 F Street, N.E., Washington, D.C. 20549.
Please call the SEC at 1-800-SEC-0330 or visit the SEC’s website for further
information on its public reference room. Allscripts’ directors, executive
officers and other members of management and employees may, under the rules of
the SEC, be deemed to be participants in the solicitation of proxies from the
stockholders of Allscripts in favor of the proposed transaction. Information
about Allscripts, its directors and its executive officers, and their
ownership of Allscripts’ securities, is set forth in its definitive proxy
statement for the 2008 Annual Meeting of Stockholders of the Company, which
was filed with the SEC on August 21, 2008.

Forward-Looking Statements

This communication contains forward-looking statements. Those
forward-looking statements include all statements other than those made solely
with respect to historical fact. Forward-looking statements may be identified
by words such as “believes”, “expects”, “anticipates”, “estimates”,
“projects”, “intends”, “should”, “seeks”, “future”, continue”, or the negative
of such terms, or other comparable terminology. Such statements include, but
are not limited to, statements about the expected benefits of the transaction
involving Allscripts, MHS and Misys, including potential synergies and cost
savings, future financial and operating results, and the combined company’s
plans and objectives. In addition, statements made in this communication about
anticipated financial results, future operational improvements and results or
regulatory approvals are also forward-looking statements. Such
forward-looking statements are subject to numerous risks, uncertainties,
assumptions and other factors that are difficult to predict and that could
cause actual results to vary materially from those expressed in or indicated
by them. Such factors may include, but are not limited to: (1) the occurrence
of any event, development, change or other circumstances that could give rise
to the termination of the merger agreement; (2) the outcome of any legal
proceedings that have been or may be instituted against Allscripts, Misys or
MHS and others following announcement of entering into the merger agreement;
(3) the inability to complete the proposed transaction due to the failure to
obtain stockholder or shareholder approval or the failure of any party to
satisfy other conditions to completion of the proposed transaction; (4) risks
that the proposed transaction disrupts current plans and operations and
potential difficulties in employee retention as a result of the merger; (5)
the ability to recognize the benefits of the merger; (6) legislative,
regulatory and economic developments; and (7) other factors described in
filings with the SEC. Many of the factors that will determine the outcome of
the subject matter of this communication are beyond Allscripts’, Misys’ and
MHS’ ability to control or predict. Allscripts can give no assurance that any
of the transactions related to the merger will be completed or that the
conditions to the merger will be satisfied. Allscripts undertakes no
obligation to revise or update any forward-looking statement, or to make any
other forward-looking statements, whether as a result of new information,
future events or otherwise. Allscripts is not responsible for updating the
information contained in this communication beyond the published date, or for
changes made to this communication by wire services or Internet service

SOURCE Allscripts Healthcare Solutions, Inc.

CONTACT: Dan Michelson, Chief Marketing Officer, +1-312-506-1217,, or Todd Stein, Senior Manager|Public Relations,
+1-312-506-1216,, or Bill Davis, Chief Financial
Officer, +1-312-506-1211,, all of Allscripts
Healthcare Solutions, Inc.
Web site:

Scroll To Top